Episode Details

Steris Q1 2026 earnings meet expectations, with a 7.3% revenue increase to $1.59 billion and EPS of $2.83. The company focuses on healthcare and life sciences, benefiting from procedure volume growth. Despite challenges like inflation and weather, Steris expanded operating margins to 19.9%. Projecting mid to high single-digit growth, Steris invests in automation and AI. Investors watch sterilization segment recovery and acquisition integration, with the stock at $207.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/a41482a617264234